2025 Q4 -tulosraportti
Äänite tulossa
1 päivä sitten
Tarjoustasot
First North Sweden
Määrä
Osto
69 627
Myynti
Määrä
50 000
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 21 282 | - | - | ||
| 117 | - | - | ||
| 300 | - | - | ||
| 3 001 | - | - | ||
| 5 000 | - | - |
Ylin
1,9VWAP
Alin
1,675VaihtoMäärä
3,1 1 762 589
VWAP
Ylin
1,9Alin
1,675VaihtoMäärä
3,1 1 762 589
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 13.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 11.2. | ||
2025 Q3 -tulosraportti 25.11.2025 | ||
2025 Q2 -tulosraportti 27.8.2025 | ||
2025 Q1 -tulosraportti 27.5.2025 | ||
2024 Q4 -tulosraportti 12.2.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·19 t sittenSprint Bioscience year-end report for January – December 2025 Sprint Bioscience AB (publ) today publishes its year-end report for the period January – December 2025. The complete report is available on the company's website. SIGNIFICANT EVENTS DURING THE FOURTH QUARTER Sprint Bioscience announced on November 24 that the company has sold its cancer program TREX1 to Gilead Sciences, Inc. The deal generated revenue of USD 14 million and potential milestone payments linked to clinical, regulatory, and commercial progress, where the total value of the agreement could amount to USD 400 million. SIGNIFICANT EVENTS AFTER THE REPORTING PERIOD No significant events after the period. FOURTH QUARTER – FINANCIAL SUMMARY Net sales during the fourth quarter amounted to 133.9 (16.3) MSEK Operating profit for the fourth quarter amounted to 117.5 (-4.9) MSEK Profit after tax for the fourth quarter amounted to 113.2 (-4.2) MSEK Earnings per share before and after dilution for the fourth quarter amounted to 1.07/1.06 (-0.06) SEK Cash flow from operating activities for the fourth quarter was 115.8 (-6.1) MSEK JANUARY – DECEMBER – FINANCIAL SUMMARY Net sales during the full-year period amounted to 167.2 (65.6) MSEK Operating profit for the full-year period amounted to 97.3 (-19.7) MSEK Profit after tax for the full-year period amounted to 91.7 (-18.3) MSEK Earnings per share before and after dilution for the full-year period amounted to 0.99/0.98 (-0.26) SEK Cash flow from operating activities for the full-year period was 83.5 (-23.4) MSEK and cash and cash equivalents at the end of the full-year period were 126.7 (25.1) MSEK The Board proposes that no dividend be paid for the financial year 2025
·18 t sittenIt looks good ?? :) I think people are selling because they had hoped for a price of 10 from the morning...
·1 päivä sittenAny thoughts on the Q4 report tomorrow?
·1 päivä sitten · MuokattuWe expect to see probably the most impressive financial report in the company's history. Gilead money: The upfront payment of 145 mio. SEK (14 mio. USD) from the TREX1 sale should be reflected in the figures. This means that the company is suddenly extremely well-capitalized. Cash balance: We are looking for a cash position of approx. 130-140 mio. SEK. This is the foundation that will ensure peace of mind for the rest of 2026. 2. The next share price triggers The market will be looking for one thing in management's comments: What about VADA? Partnership agreement: Sprint has stated that they are working intensively to find a partner for the VADA program. If they hint that negotiations are advanced, the stock will probably take off Operations: We expect to see them use the money wisely and not drastically increase expenses... Best Case: The figures confirm the strength + positive future outlook. The stock breaks through resistance at 2.06 SEK and continues upwards. Worst Case Even if the financial report is good, many choose to sell off because "the news is out". Here it might dive Stolen from ai and news from nordnet
·1 päivä sittenDiscord for more information about the company. https://discord.com/invite/7TQ5m98bM
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
Äänite tulossa
1 päivä sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·19 t sittenSprint Bioscience year-end report for January – December 2025 Sprint Bioscience AB (publ) today publishes its year-end report for the period January – December 2025. The complete report is available on the company's website. SIGNIFICANT EVENTS DURING THE FOURTH QUARTER Sprint Bioscience announced on November 24 that the company has sold its cancer program TREX1 to Gilead Sciences, Inc. The deal generated revenue of USD 14 million and potential milestone payments linked to clinical, regulatory, and commercial progress, where the total value of the agreement could amount to USD 400 million. SIGNIFICANT EVENTS AFTER THE REPORTING PERIOD No significant events after the period. FOURTH QUARTER – FINANCIAL SUMMARY Net sales during the fourth quarter amounted to 133.9 (16.3) MSEK Operating profit for the fourth quarter amounted to 117.5 (-4.9) MSEK Profit after tax for the fourth quarter amounted to 113.2 (-4.2) MSEK Earnings per share before and after dilution for the fourth quarter amounted to 1.07/1.06 (-0.06) SEK Cash flow from operating activities for the fourth quarter was 115.8 (-6.1) MSEK JANUARY – DECEMBER – FINANCIAL SUMMARY Net sales during the full-year period amounted to 167.2 (65.6) MSEK Operating profit for the full-year period amounted to 97.3 (-19.7) MSEK Profit after tax for the full-year period amounted to 91.7 (-18.3) MSEK Earnings per share before and after dilution for the full-year period amounted to 0.99/0.98 (-0.26) SEK Cash flow from operating activities for the full-year period was 83.5 (-23.4) MSEK and cash and cash equivalents at the end of the full-year period were 126.7 (25.1) MSEK The Board proposes that no dividend be paid for the financial year 2025·18 t sittenIt looks good ?? :) I think people are selling because they had hoped for a price of 10 from the morning...
- ·1 päivä sittenAny thoughts on the Q4 report tomorrow?·1 päivä sitten · MuokattuWe expect to see probably the most impressive financial report in the company's history. Gilead money: The upfront payment of 145 mio. SEK (14 mio. USD) from the TREX1 sale should be reflected in the figures. This means that the company is suddenly extremely well-capitalized. Cash balance: We are looking for a cash position of approx. 130-140 mio. SEK. This is the foundation that will ensure peace of mind for the rest of 2026. 2. The next share price triggers The market will be looking for one thing in management's comments: What about VADA? Partnership agreement: Sprint has stated that they are working intensively to find a partner for the VADA program. If they hint that negotiations are advanced, the stock will probably take off Operations: We expect to see them use the money wisely and not drastically increase expenses... Best Case: The figures confirm the strength + positive future outlook. The stock breaks through resistance at 2.06 SEK and continues upwards. Worst Case Even if the financial report is good, many choose to sell off because "the news is out". Here it might dive Stolen from ai and news from nordnet
- ·1 päivä sittenDiscord for more information about the company. https://discord.com/invite/7TQ5m98bM
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
69 627
Myynti
Määrä
50 000
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 21 282 | - | - | ||
| 117 | - | - | ||
| 300 | - | - | ||
| 3 001 | - | - | ||
| 5 000 | - | - |
Ylin
1,9VWAP
Alin
1,675VaihtoMäärä
3,1 1 762 589
VWAP
Ylin
1,9Alin
1,675VaihtoMäärä
3,1 1 762 589
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 13.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 11.2. | ||
2025 Q3 -tulosraportti 25.11.2025 | ||
2025 Q2 -tulosraportti 27.8.2025 | ||
2025 Q1 -tulosraportti 27.5.2025 | ||
2024 Q4 -tulosraportti 12.2.2025 |
2025 Q4 -tulosraportti
Äänite tulossa
1 päivä sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 13.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 11.2. | ||
2025 Q3 -tulosraportti 25.11.2025 | ||
2025 Q2 -tulosraportti 27.8.2025 | ||
2025 Q1 -tulosraportti 27.5.2025 | ||
2024 Q4 -tulosraportti 12.2.2025 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·19 t sittenSprint Bioscience year-end report for January – December 2025 Sprint Bioscience AB (publ) today publishes its year-end report for the period January – December 2025. The complete report is available on the company's website. SIGNIFICANT EVENTS DURING THE FOURTH QUARTER Sprint Bioscience announced on November 24 that the company has sold its cancer program TREX1 to Gilead Sciences, Inc. The deal generated revenue of USD 14 million and potential milestone payments linked to clinical, regulatory, and commercial progress, where the total value of the agreement could amount to USD 400 million. SIGNIFICANT EVENTS AFTER THE REPORTING PERIOD No significant events after the period. FOURTH QUARTER – FINANCIAL SUMMARY Net sales during the fourth quarter amounted to 133.9 (16.3) MSEK Operating profit for the fourth quarter amounted to 117.5 (-4.9) MSEK Profit after tax for the fourth quarter amounted to 113.2 (-4.2) MSEK Earnings per share before and after dilution for the fourth quarter amounted to 1.07/1.06 (-0.06) SEK Cash flow from operating activities for the fourth quarter was 115.8 (-6.1) MSEK JANUARY – DECEMBER – FINANCIAL SUMMARY Net sales during the full-year period amounted to 167.2 (65.6) MSEK Operating profit for the full-year period amounted to 97.3 (-19.7) MSEK Profit after tax for the full-year period amounted to 91.7 (-18.3) MSEK Earnings per share before and after dilution for the full-year period amounted to 0.99/0.98 (-0.26) SEK Cash flow from operating activities for the full-year period was 83.5 (-23.4) MSEK and cash and cash equivalents at the end of the full-year period were 126.7 (25.1) MSEK The Board proposes that no dividend be paid for the financial year 2025·18 t sittenIt looks good ?? :) I think people are selling because they had hoped for a price of 10 from the morning...
- ·1 päivä sittenAny thoughts on the Q4 report tomorrow?·1 päivä sitten · MuokattuWe expect to see probably the most impressive financial report in the company's history. Gilead money: The upfront payment of 145 mio. SEK (14 mio. USD) from the TREX1 sale should be reflected in the figures. This means that the company is suddenly extremely well-capitalized. Cash balance: We are looking for a cash position of approx. 130-140 mio. SEK. This is the foundation that will ensure peace of mind for the rest of 2026. 2. The next share price triggers The market will be looking for one thing in management's comments: What about VADA? Partnership agreement: Sprint has stated that they are working intensively to find a partner for the VADA program. If they hint that negotiations are advanced, the stock will probably take off Operations: We expect to see them use the money wisely and not drastically increase expenses... Best Case: The figures confirm the strength + positive future outlook. The stock breaks through resistance at 2.06 SEK and continues upwards. Worst Case Even if the financial report is good, many choose to sell off because "the news is out". Here it might dive Stolen from ai and news from nordnet
- ·1 päivä sittenDiscord for more information about the company. https://discord.com/invite/7TQ5m98bM
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
69 627
Myynti
Määrä
50 000
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 21 282 | - | - | ||
| 117 | - | - | ||
| 300 | - | - | ||
| 3 001 | - | - | ||
| 5 000 | - | - |
Ylin
1,9VWAP
Alin
1,675VaihtoMäärä
3,1 1 762 589
VWAP
Ylin
1,9Alin
1,675VaihtoMäärä
3,1 1 762 589
Välittäjätilasto
Dataa ei löytynyt